Ulcerative Colitis Market – Biologics Transform Chronic Disease Management
The ulcerative colitis market is growing as diagnosis rates improve and healthcare providers adopt more advanced treatment options for this chronic inflammatory bowel disease. The market was valued at USD 7.96 billion in 2024 and is projected to reach USD 13.79 billion by 2035, growing at a CAGR of 5.12%. 1098 Ulcerative colitis affects the large intestine and can cause symptoms such as...
0 Kommentare 0 Geteilt 132 Ansichten 0 Bewertungen